PGNY vs DOCS

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 22, 2026

PGNY

50.4
AI Score
VS
PGNY Wins

DOCS

48.1
AI Score

Investment Advisor Scores

PGNY

50score
Recommendation
HOLD

DOCS

48score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric PGNY DOCS Winner
Revenue 679.01M 156.62M PGNY
Net Income 52.28M 24.32M PGNY
Gross Margin 25.4% 84.9% DOCS
Net Margin 7.7% 15.5% DOCS
Operating Income 75.38M 33.64M PGNY
ROE 11.5% 2.7% PGNY
ROA 7.3% 2.2% PGNY
Total Assets 715.84M 1.08B DOCS
Cash 152.63M 273.60M DOCS
Current Ratio 2.14 6.08 DOCS
Free Cash Flow 83.81M 41.92M PGNY

Relative Price Performance (Last 90 Days)

PGNY 1M: +8.4% · 3M: -7.4% DOCS 1M: +26.7% · 3M: +64.2%

Current Technical Phase

PGNY

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 61

RSI (14): 60.6 · Price: $28.44

DOCS

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (11.9% over 20 days), RSI 75

RSI (14): 74.6 · Price: $33.58

Fundamentals Snapshot

Metric PGNY DOCS
Market Cap — —
Forward P/E 12.3 20.7
Trailing P/E 30.4 39.2
Revenue (TTM) — —
Revenue Growth 0.1% 0.1%
Gross Margin 0.2% 0.9%
Operating Margin 0.1% 0.2%
EPS 0.94 0.85
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, PGNY is currently the stronger investment candidate, winning 6 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.